← Back to Search

CM-1600 for Dehydration

N/A
Waitlist Available
Research Sponsored by Zynex Monitoring Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 - 60 minutes
Awards & highlights

Study Summary

This trial is testing a new device that monitors vital signs during blood donation. Up to 227 healthy adults will use the device during donation, and their vital signs will be monitored before, during, and after.

Eligible Conditions
  • Dehydration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 - 60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 - 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Specificity and sensitivity of minor blood loss detection
Secondary outcome measures
Correlation between physiological parameters and relative index
Right vs left antecubital blood donation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Blood LossExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CM-1600
2023
N/A
~380

Find a Location

Who is running the clinical trial?

Zynex Monitoring SolutionsLead Sponsor
8 Previous Clinical Trials
450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still availability for participants in this trial?

"Yes, the research posted on clinicaltrials.gov demonstrates that this trial is presently enrolling patients. It was initially listed on September 14th 2022 and has been revised as recently as October 25th 2022. The investigators are hoping to recruit 227 participants from 2 different sites."

Answered by AI

What is the overall size of this clinical investigation?

"Affirmative. Clinicaltrials.gov records that this clinical trial is enlisting patients; the original posting was on September 14th 2022 and it has been modified most recently on October 25th 2022. This research aims to enrol 227 people from two sites."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
What site did they apply to?
Vitalant Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~136 spots leftby Apr 2025